Radiotherapy for gastric cancer: A systematic review and meta-analysis

Tumor Biology

Volumn 35, Issue 1, 2014, Pages 387-396

  Pang, Xiaohui ^a   Wei, Wanqing ^b   Leng, Weibing ^a   Chen, Qi ^a   Xia, Hongwei ^a   Chen, Liu ^a   Li, Ronghui ^a  

^a SICHUAN UNIVERSITY   (China)

^b SECOND HOSPITAL OF TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Gastric cancer; Meta analysis; Radiotherapy; Stomach neoplasms

Indexed keywords

ARTICLE; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; HUMAN; META ANALYSIS; OVERALL SURVIVAL; PERIOPERATIVE PERIOD; POSTOPERATIVE CARE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); STOMACH CANCER; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

CHEMOTHERAPY, ADJUVANT; HUMANS; POSTOPERATIVE PERIOD; RADIOTHERAPY, ADJUVANT; STOMACH NEOPLASMS;

EID: 84894447698     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1054-y     Document Type: Article

References (36)

1. de Martel C, Forman D, Plummer M. Gastric cancer: epidemiology and risk factors. Gastroenterol Clin North Am. 2013;42:219-40.
2. Kamangar F, Dores GM, AndersonWF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol: Off J Am Soc. 2006;24:2137-50.
3. Krijnen P, den Dulk M. Meershoek-Klein Kranenbarg E, Jansen-Landheer ML, van de Velde CJ: Improved survival after resectable non-cardia gastric cancer in the Netherlands: the importance of surgical training and quality control. Eur J Surg Oncol: J Eur Soc Surg Oncol British Assoc Surg Oncol. 2009;35:715-20.
4. Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, Joypaul V, et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical cooperative group. Br J Cancer. 1999;79:1522-30.
5. Lim DH, Kim DY, Kang MK, Kim YI, Kang WK, Park CK, et al. Patterns of failure in gastric carcinoma after D2 gastrectomy and chemoradiotherapy: a radiation oncologist's view. Br J Cancer. 2004;91:11-7.
6. Hartgrink HH, van de Velde CJ, Putter H, Bonenkamp JJ. Klein Kranenbarg E, Songun I, Welvaart K, van Krieken JH, Meijer S, Plukker JT, van Elk PJ, Obertop H, Gouma DJ, van Lanschot JJ, Taat CW, de Graaf PW, von Meyenfeldt MF, Tilanus H, Sasako M: Extended lymph node dissection for gastric cancer:whomay benefit? Final results of the randomized Dutch Gastric Cancer Group trial. J Clin Oncol: Off J Am Soc. 2004;22:2069-77.
7. Paoletti X, Oba K, Burzykowski T, Michiels S, Ohashi Y, Pignon JP, et al. Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis. JAMA. 2010;303:1729-37.
8. Zhang ZX, Gu XZ, Yin WB, Huang GJ, Zhang DW, Zhang RG. Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of adenocarcinoma of gastric cardia (AGC) - report on 370 patients. Int J Radiat Oncol Biol Phys. 1998;42:929-34.
9. Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001;345:725-30.
10. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 1998;17:2815-34.
11. Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into metaanalysis. Trials. 2007;8:16.
12. Abe M, Shibamoto Y, Takahashi M, Manabe T, Tobe T, Inamoto T. Intraoperative radiotherapy in carcinoma of the stomach and pancreas. World J Surg. 1987;11:459-64.
13. Moertel CG. Childs Jr DS, Reitemeier RJ, Colby Jr MY, Holbrook MA: Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet. 1969;2:865-7.
14. Goffin JC, Machin D. Treatment of patients with gastric cancer by surgery, radiotherapy, and chemotherapy: preliminary results of an EORTC randomized study. Recent Results Cancer Res Fortschritte der Krebsforschung Progres dans les recherches sur le cancer. 1978;68:208-11.
15. Dent DM, Werner ID, Novis B. Prospective randomized trial of combined oncological therapy for gastric carcinoma. Cancer. 1979;44:385-91.
16. Hazel JJ, Thirlwell MP, Huggins M, Maksymiuk A, MacFarlane JK. Multi-drug chemotherapy with and without radiation for carcinoma of the stomach and pancreas: a prospective randomized trial. J Can Assoc Radiol. 1981;32:164-5.
17. Moertel CG, Childs DS, O'Fallon JR, Holbrook MA, Schutt AJ, Reitemeier RJ. Combined 5-fluorouracil and radiation therapy as a surgical adjuvant for poor prognosis gastric carcinoma. J Clin Oncol: Off J Am Soc. 1984;2:1249-54.
18. Allum WH, Hallissey MT, Ward LC, Hockey MS. A controlled, prospective, randomised trial of adjuvant chemotherapy or radiotherapy in resectable gastric cancer: interim report. British stomach cancer group. Br J Cancer. 1989;60:739-44.
19. Bleiberg H, Goffin JC, Dalesio O, Buyse M, Pector JC, Gignoux M, et al. Adjuvant radiotherapy and chemotherapy in resectable gastric cancer. A randomized trial of the gastro-intestinal tract cancer cooperative group of the EORTC. Eur J Surg Oncol: J Eur Soc Surg Oncol British Assoc Surg Oncol. 1989;15:535-43.
20. Hallissey MT, Dunn JA, Ward LC, Allum WH. The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: five-year follow-up. Lancet. 1994;343:1309-12.
21. Shchepotin IB, Evans SR, Chorny V, Osinsky S, Buras RR, Maligonov P, et al. Intensive preoperative radiotherapy with local hyperthermia for the treatment of gastric carcinoma. Surg Oncol. 1994;3:37-44.
22. Kelsen DP. Postoperative adjuvant chemoradiation therapy for patients with resected gastric cancer: Intergroup 116. J Clin Oncol: Off J Am Soc. 2000;18:32S-4.
23. SkoropadVY, BerdovBA,MardynskiYS, Titova LN.Aprospective, randomized trial of pre-operative and intraoperative radiotherapy versus surgery alone in resectable gastric cancer. Eur J Surg Oncol. 2000;26:773-9.
24. Skoropad V, Berdov B, Zagrebin V. Concentrated preoperative radiotherapy for resectable gastric cancer: 20-years follow-up of a randomized trial. J Surg Oncol. 2002;80:72-8.
25. Fu S, Lu JJ, Zhang Q, Yang Z, Peng L, Xiong F. Intraoperative radiotherapy combined with adjuvant chemoradiotherapy for locally advanced gastric adenocarcinoma. Int J Radiat Oncol Biol Phys. 2008;72:1488-94.
26. Schwartz GK, Winter K, Minsky BD, Crane C, Thomson PJ, Anne P, et al. Randomized phase ii trial evaluating two paclitaxel and cisplatin-containing chemoradiation regimens as adjuvant therapy in resected gastric cancer (RTOG-0114). J Clin Oncol. 2009;27:1956-62.
27. Stahl M, Walz MK, Stuschke M, Lehmann N, Meyer HJ, Riera- Knorrenschild J, et al. Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol. 2009;27:851-6.
28. Valentini V, Cellini F, Minsky BD, Mattiucci GC, Balducci M, D'Agostino G, et al. Survival after radiotherapy in gastric cancer: systematic review and meta-analysis. Radiother Oncol. 2009;92:176-83.
29. Bamias A, Karina M, Papakostas P, Kostopoulos I, Bobos M, Vourli G, et al. A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer. Cancer Chemother Pharmacol. 2010;65:1009-21.
30. Dikken JL, Jansen EP, Cats A, Bakker B, Hartgrink HH, Kranenbarg EM, et al. Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer. J Clin Oncol. 2010;28:2430-6.
31. Kwon HC, Kim MC, Kim KH, Jang JS, Oh SY, Kim SH, et al. Adjuvant chemoradiation versus chemotherapy in completely resected advanced gastric cancer with D2 nodal dissection. Asia-Pac J Clin Oncol. 2010;6:278-85.
32. KimTH, Park SR, RyuKW, KimYW, Bae JM, Lee JH, et al. Phase 3 trial of postoperative chemotherapy alone versus chemoradiation therapy in stage III-IV gastric cancer treated with R0 gastrectomy and D2 lymph node dissection. Int J Radiat Oncol Biol Phys. 2012;84:e585-92.
33. Lee J. Lim do H, Kim S, Park SH, Park JO, Park YS, Lim HY, Choi MG, Sohn TS, Noh JH, Bae JM, Ahn YC, Sohn I, Jung SH, Park CK, Kim KM, Kang WK: Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the artist trial. J Clin Oncol. 2012;30:268-73.
34. Smalley SR, Benedetti JK, Haller DG, Hundahl SA, Estes NC, Ajani JA, et al. Updated analysis of SWOG-directed intergroup study 0116: a phase iii trial of adjuvant radio chemotherapy versus observation after curative gastric cancer resection. J Clin Oncol. 2012;30:2327-33.
35. Yu C, Yu R, Zhu W, Song Y, Li T. Intensity-modulated radiotherapy combined with chemotherapy for the treatment of gastric cancer patients after standard D1/D2 surgery. J Cancer Res Clin Oncol. 2012;138:255-9.
36. ZhuWG,Xua DF, Pu J, Zong CD, Li T, Tao GZ, et al. A randomized, controlled, multicenter study comparing intensity-modulated radiotherapy plus concurrent chemotherapy with chemotherapy alone in gastric cancer patients with D2 resection. Radiother Oncol. 2012;104:361-6.